| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Women's Health | 33 | 2023 | 242 | 4.630 |
Why?
|
| Menopause | 23 | 2023 | 131 | 3.010 |
Why?
|
| Coronary Artery Disease | 8 | 2022 | 139 | 2.370 |
Why?
|
| Cardiovascular Diseases | 16 | 2023 | 428 | 1.680 |
Why?
|
| Adiposity | 10 | 2022 | 45 | 1.570 |
Why?
|
| Pediatric Obesity | 2 | 2022 | 48 | 1.500 |
Why?
|
| Intra-Abdominal Fat | 9 | 2021 | 44 | 1.370 |
Why?
|
| Perimenopause | 3 | 2022 | 23 | 1.370 |
Why?
|
| Middle Aged | 72 | 2023 | 10239 | 1.310 |
Why?
|
| Vascular Calcification | 4 | 2022 | 11 | 1.300 |
Why?
|
| Coronary Vessels | 7 | 2022 | 47 | 1.270 |
Why?
|
| Female | 85 | 2023 | 17018 | 1.260 |
Why?
|
| Risk Factors | 36 | 2023 | 2593 | 1.150 |
Why?
|
| Depression | 8 | 2016 | 481 | 1.040 |
Why?
|
| Calcinosis | 4 | 2016 | 50 | 1.030 |
Why?
|
| Testosterone | 4 | 2015 | 32 | 1.020 |
Why?
|
| Humans | 91 | 2023 | 31070 | 1.010 |
Why?
|
| Longitudinal Studies | 21 | 2023 | 1505 | 1.000 |
Why?
|
| Body Mass Index | 15 | 2022 | 453 | 0.950 |
Why?
|
| Employment | 2 | 2022 | 43 | 0.910 |
Why?
|
| Adult | 42 | 2023 | 8949 | 0.820 |
Why?
|
| Adipose Tissue | 9 | 2023 | 78 | 0.810 |
Why?
|
| Obesity, Abdominal | 5 | 2018 | 21 | 0.800 |
Why?
|
| Stress, Psychological | 3 | 2016 | 254 | 0.800 |
Why?
|
| Sleep | 6 | 2020 | 322 | 0.790 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 61 | 0.770 |
Why?
|
| Postoperative Complications | 5 | 2020 | 997 | 0.750 |
Why?
|
| Obesity | 6 | 2022 | 307 | 0.740 |
Why?
|
| Disease Progression | 6 | 2022 | 830 | 0.710 |
Why?
|
| Metabolic Syndrome | 4 | 2020 | 68 | 0.700 |
Why?
|
| Menopause, Premature | 1 | 2020 | 6 | 0.700 |
Why?
|
| Hysterectomy | 1 | 2020 | 21 | 0.700 |
Why?
|
| United States | 23 | 2023 | 2375 | 0.680 |
Why?
|
| Exercise | 6 | 2022 | 505 | 0.640 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2022 | 818 | 0.640 |
Why?
|
| Carotid Intima-Media Thickness | 7 | 2023 | 24 | 0.600 |
Why?
|
| Fibrinogen | 2 | 2016 | 20 | 0.570 |
Why?
|
| Carotid Artery Diseases | 3 | 2023 | 41 | 0.560 |
Why?
|
| Follow-Up Studies | 18 | 2021 | 1935 | 0.560 |
Why?
|
| Pain | 2 | 2023 | 426 | 0.500 |
Why?
|
| Self Efficacy | 1 | 2014 | 57 | 0.460 |
Why?
|
| Atherosclerosis | 4 | 2018 | 76 | 0.440 |
Why?
|
| Social Support | 1 | 2014 | 194 | 0.420 |
Why?
|
| Postmenopause | 3 | 2021 | 62 | 0.410 |
Why?
|
| Sex Offenses | 2 | 2023 | 22 | 0.410 |
Why?
|
| Coronary Angiography | 4 | 2018 | 99 | 0.410 |
Why?
|
| Cross-Sectional Studies | 12 | 2022 | 1008 | 0.410 |
Why?
|
| Role | 1 | 2012 | 8 | 0.400 |
Why?
|
| Child | 5 | 2023 | 1431 | 0.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 190 | 0.400 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 128 | 0.390 |
Why?
|
| Cohort Studies | 8 | 2020 | 2045 | 0.390 |
Why?
|
| Insulin Resistance | 3 | 2022 | 60 | 0.370 |
Why?
|
| Calcium | 3 | 2022 | 503 | 0.370 |
Why?
|
| Cholesterol, HDL | 5 | 2022 | 30 | 0.370 |
Why?
|
| Quality of Life | 4 | 2022 | 696 | 0.360 |
Why?
|
| General Surgery | 3 | 2015 | 58 | 0.360 |
Why?
|
| Estradiol | 5 | 2022 | 46 | 0.360 |
Why?
|
| Laparoscopy | 4 | 2015 | 171 | 0.350 |
Why?
|
| Time Factors | 7 | 2020 | 1681 | 0.340 |
Why?
|
| Aged | 17 | 2022 | 10079 | 0.340 |
Why?
|
| Chicago | 7 | 2014 | 943 | 0.340 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 86 | 0.330 |
Why?
|
| Residence Characteristics | 2 | 2023 | 226 | 0.320 |
Why?
|
| Quality Improvement | 3 | 2014 | 165 | 0.320 |
Why?
|
| Lipoproteins, HDL | 4 | 2022 | 30 | 0.320 |
Why?
|
| Retrospective Studies | 12 | 2017 | 3665 | 0.310 |
Why?
|
| Odds Ratio | 7 | 2016 | 293 | 0.310 |
Why?
|
| Socioeconomic Factors | 7 | 2020 | 335 | 0.290 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2020 | 22 | 0.280 |
Why?
|
| Patient Compliance | 5 | 2013 | 158 | 0.280 |
Why?
|
| Self Care | 4 | 2013 | 91 | 0.280 |
Why?
|
| Waist Circumference | 6 | 2022 | 36 | 0.280 |
Why?
|
| Absorptiometry, Photon | 4 | 2015 | 83 | 0.280 |
Why?
|
| Herniorrhaphy | 3 | 2015 | 31 | 0.270 |
Why?
|
| Aortic Diseases | 2 | 2018 | 7 | 0.270 |
Why?
|
| Lipoproteins | 2 | 2022 | 11 | 0.270 |
Why?
|
| Colectomy | 2 | 2016 | 23 | 0.260 |
Why?
|
| Surveys and Questionnaires | 7 | 2017 | 1209 | 0.260 |
Why?
|
| Age Factors | 6 | 2020 | 874 | 0.250 |
Why?
|
| Incidence | 5 | 2021 | 790 | 0.250 |
Why?
|
| Educational Measurement | 2 | 2015 | 61 | 0.250 |
Why?
|
| Carotid Arteries | 5 | 2021 | 53 | 0.250 |
Why?
|
| Prospective Studies | 10 | 2022 | 1898 | 0.240 |
Why?
|
| Biomarkers | 4 | 2021 | 733 | 0.240 |
Why?
|
| Prevalence | 5 | 2022 | 500 | 0.220 |
Why?
|
| Linear Models | 5 | 2016 | 273 | 0.220 |
Why?
|
| Vascular Stiffness | 2 | 2020 | 9 | 0.210 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 1 | 0.210 |
Why?
|
| Pelvic Floor Disorders | 1 | 2023 | 10 | 0.210 |
Why?
|
| Urinary Incontinence | 1 | 2023 | 24 | 0.210 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2011 | 15 | 0.210 |
Why?
|
| Complementary Therapies | 1 | 2022 | 10 | 0.210 |
Why?
|
| Abortion, Habitual | 1 | 2022 | 1 | 0.210 |
Why?
|
| Mexican Americans | 2 | 2013 | 28 | 0.210 |
Why?
|
| Infertility | 1 | 2022 | 8 | 0.210 |
Why?
|
| Community Health Workers | 2 | 2013 | 29 | 0.200 |
Why?
|
| Heart Failure | 3 | 2010 | 223 | 0.200 |
Why?
|
| Disease Management | 2 | 2015 | 126 | 0.200 |
Why?
|
| Weather | 1 | 2022 | 18 | 0.200 |
Why?
|
| Family Characteristics | 1 | 2022 | 20 | 0.200 |
Why?
|
| Child Abuse | 1 | 2022 | 38 | 0.200 |
Why?
|
| Income | 1 | 2022 | 80 | 0.190 |
Why?
|
| Premenopause | 3 | 2017 | 21 | 0.190 |
Why?
|
| Adipokines | 1 | 2021 | 8 | 0.190 |
Why?
|
| Brain Ischemia | 1 | 2022 | 75 | 0.190 |
Why?
|
| Poverty | 1 | 2022 | 97 | 0.190 |
Why?
|
| Body Composition | 2 | 2019 | 67 | 0.190 |
Why?
|
| Urban Population | 1 | 2022 | 148 | 0.190 |
Why?
|
| Estrogens | 3 | 2021 | 36 | 0.180 |
Why?
|
| Weight Gain | 3 | 2022 | 70 | 0.180 |
Why?
|
| Acute Pain | 1 | 2020 | 20 | 0.180 |
Why?
|
| Multimorbidity | 1 | 2020 | 8 | 0.180 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 375 | 0.180 |
Why?
|
| Abdominal Fat | 2 | 2021 | 10 | 0.180 |
Why?
|
| Ovariectomy | 1 | 2020 | 27 | 0.180 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 11 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2020 | 76 | 0.170 |
Why?
|
| Cardiovascular System | 1 | 2019 | 16 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2013 | 214 | 0.170 |
Why?
|
| Self Report | 3 | 2020 | 231 | 0.170 |
Why?
|
| Walking Speed | 1 | 2019 | 43 | 0.170 |
Why?
|
| Pandemics | 1 | 2021 | 274 | 0.160 |
Why?
|
| Pain Measurement | 2 | 2020 | 489 | 0.160 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 74 | 0.160 |
Why?
|
| Aortography | 1 | 2018 | 10 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 35 | 0.160 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 38 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2020 | 303 | 0.160 |
Why?
|
| Breast Feeding | 2 | 2011 | 156 | 0.160 |
Why?
|
| Stroke | 1 | 2022 | 315 | 0.150 |
Why?
|
| Snacks | 1 | 2018 | 2 | 0.150 |
Why?
|
| Patient Education as Topic | 2 | 2010 | 161 | 0.150 |
Why?
|
| Food Preferences | 1 | 2018 | 22 | 0.150 |
Why?
|
| Logistic Models | 6 | 2016 | 410 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2020 | 534 | 0.150 |
Why?
|
| Consumer Behavior | 1 | 2018 | 20 | 0.150 |
Why?
|
| Delay Discounting | 1 | 2018 | 27 | 0.150 |
Why?
|
| Blood Pressure | 5 | 2023 | 262 | 0.140 |
Why?
|
| Male | 18 | 2022 | 16499 | 0.140 |
Why?
|
| Beverages | 1 | 2016 | 10 | 0.140 |
Why?
|
| Waist-Height Ratio | 1 | 2016 | 6 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 14 | 0.140 |
Why?
|
| Menstrual Cycle | 2 | 2007 | 31 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2016 | 20 | 0.140 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 6 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Cholesterol, LDL | 3 | 2023 | 33 | 0.130 |
Why?
|
| Motivation | 2 | 2014 | 103 | 0.130 |
Why?
|
| Circadian Rhythm | 3 | 2010 | 294 | 0.130 |
Why?
|
| Dyspareunia | 1 | 2015 | 7 | 0.130 |
Why?
|
| Perception | 1 | 2016 | 85 | 0.130 |
Why?
|
| Sexuality | 1 | 2015 | 17 | 0.130 |
Why?
|
| Carcinoma | 1 | 2016 | 64 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 82 | 0.130 |
Why?
|
| Gastrectomy | 1 | 2015 | 34 | 0.130 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 12 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 61 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 32 | 0.130 |
Why?
|
| Clinical Clerkship | 1 | 2015 | 21 | 0.130 |
Why?
|
| Certification | 1 | 2015 | 49 | 0.130 |
Why?
|
| Writing | 1 | 2015 | 22 | 0.130 |
Why?
|
| Mass Screening | 1 | 2016 | 186 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 16 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 17 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2016 | 225 | 0.120 |
Why?
|
| Meals | 1 | 2014 | 12 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 29 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Hernia, Hiatal | 1 | 2014 | 11 | 0.120 |
Why?
|
| Hernia, Ventral | 1 | 2014 | 19 | 0.120 |
Why?
|
| Prognosis | 5 | 2020 | 924 | 0.120 |
Why?
|
| Surgical Mesh | 1 | 2014 | 24 | 0.120 |
Why?
|
| Prejudice | 2 | 2013 | 41 | 0.120 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2014 | 10 | 0.120 |
Why?
|
| Personal Autonomy | 1 | 2014 | 9 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2015 | 91 | 0.120 |
Why?
|
| Cell Cycle Proteins | 2 | 2004 | 17 | 0.120 |
Why?
|
| Aorta | 2 | 2011 | 28 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2014 | 123 | 0.110 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2004 | 41 | 0.110 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 49 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 225 | 0.110 |
Why?
|
| Body Image | 1 | 2014 | 31 | 0.110 |
Why?
|
| Comorbidity | 2 | 2015 | 508 | 0.110 |
Why?
|
| Social Perception | 1 | 2013 | 23 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 44 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2015 | 97 | 0.110 |
Why?
|
| Chronic Pain | 1 | 2014 | 111 | 0.110 |
Why?
|
| Morbidity | 2 | 2014 | 65 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2004 | 172 | 0.110 |
Why?
|
| Triglycerides | 3 | 2022 | 47 | 0.110 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2013 | 32 | 0.110 |
Why?
|
| Body Fat Distribution | 1 | 2012 | 12 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2020 | 1055 | 0.100 |
Why?
|
| Decision Making | 1 | 2015 | 237 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2015 | 227 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 275 | 0.100 |
Why?
|
| Pulsatile Flow | 1 | 2011 | 3 | 0.100 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 2 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2011 | 74 | 0.090 |
Why?
|
| Directive Counseling | 1 | 2010 | 14 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2010 | 40 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2016 | 3809 | 0.090 |
Why?
|
| Progesterone Congeners | 1 | 2010 | 1 | 0.090 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2010 | 3 | 0.090 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2010 | 5 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 21 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2018 | 718 | 0.090 |
Why?
|
| Biological Availability | 1 | 2009 | 25 | 0.090 |
Why?
|
| Survival Rate | 3 | 2015 | 407 | 0.080 |
Why?
|
| Subcutaneous Fat | 1 | 2009 | 10 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2016 | 354 | 0.080 |
Why?
|
| Hostility | 1 | 2009 | 22 | 0.080 |
Why?
|
| Pulse Wave Analysis | 2 | 2020 | 4 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 551 | 0.080 |
Why?
|
| Hot Flashes | 2 | 2020 | 16 | 0.080 |
Why?
|
| Health Education | 1 | 2008 | 41 | 0.080 |
Why?
|
| Single-Blind Method | 3 | 2013 | 120 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2021 | 271 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2014 | 356 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2004 | 59 | 0.070 |
Why?
|
| Blood Glucose | 3 | 2014 | 120 | 0.070 |
Why?
|
| Estrone | 1 | 2007 | 6 | 0.070 |
Why?
|
| Postural Balance | 1 | 2008 | 124 | 0.070 |
Why?
|
| Pregnanediol | 1 | 2007 | 6 | 0.070 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 9 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2008 | 114 | 0.070 |
Why?
|
| Aging | 2 | 2015 | 1727 | 0.070 |
Why?
|
| Research Design | 1 | 2008 | 219 | 0.070 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2006 | 9 | 0.070 |
Why?
|
| Pregnancy | 2 | 2022 | 405 | 0.070 |
Why?
|
| Gonadal Hormones | 1 | 2005 | 3 | 0.070 |
Why?
|
| Vertigo | 1 | 2005 | 8 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 318 | 0.060 |
Why?
|
| Illinois | 3 | 2014 | 267 | 0.060 |
Why?
|
| Phototherapy | 1 | 2005 | 38 | 0.060 |
Why?
|
| Schools | 1 | 2005 | 51 | 0.060 |
Why?
|
| Reference Values | 3 | 2013 | 229 | 0.060 |
Why?
|
| Students | 1 | 2005 | 40 | 0.060 |
Why?
|
| Adolescent | 2 | 2014 | 2403 | 0.060 |
Why?
|
| Sleep Deprivation | 1 | 2005 | 65 | 0.060 |
Why?
|
| Apolipoproteins | 1 | 2023 | 9 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2003 | 5 | 0.060 |
Why?
|
| K562 Cells | 1 | 2003 | 6 | 0.060 |
Why?
|
| Telomerase | 1 | 2003 | 10 | 0.060 |
Why?
|
| Histones | 1 | 2003 | 28 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2023 | 11 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 3 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2022 | 5 | 0.050 |
Why?
|
| Sex Factors | 2 | 2018 | 510 | 0.050 |
Why?
|
| Social Class | 1 | 2023 | 70 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2022 | 5 | 0.050 |
Why?
|
| Life Style | 3 | 2011 | 226 | 0.050 |
Why?
|
| Stillbirth | 1 | 2022 | 4 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2022 | 32 | 0.050 |
Why?
|
| Length of Stay | 2 | 2014 | 339 | 0.050 |
Why?
|
| Physical Abuse | 1 | 2022 | 2 | 0.050 |
Why?
|
| Apoptosis | 1 | 2003 | 260 | 0.050 |
Why?
|
| Benchmarking | 1 | 2022 | 46 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2004 | 1316 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2020 | 14 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2019 | 25 | 0.040 |
Why?
|
| Recurrence | 2 | 2014 | 375 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 149 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 17 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 344 | 0.040 |
Why?
|
| Food Dispensers, Automatic | 1 | 2018 | 2 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2011 | 132 | 0.040 |
Why?
|
| Tomography | 1 | 2018 | 13 | 0.040 |
Why?
|
| Nutritive Value | 1 | 2018 | 20 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 37 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 199 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 240 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 197 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 1133 | 0.040 |
Why?
|
| Diet | 1 | 2018 | 194 | 0.040 |
Why?
|
| Pericardium | 1 | 2017 | 21 | 0.040 |
Why?
|
| Hospitalization | 2 | 2010 | 336 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 429 | 0.030 |
Why?
|
| Energy Intake | 1 | 2016 | 73 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 41 | 0.030 |
Why?
|
| Climacteric | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cognition | 1 | 2004 | 1427 | 0.030 |
Why?
|
| Hernia, Umbilical | 1 | 2015 | 2 | 0.030 |
Why?
|
| Causality | 1 | 2015 | 54 | 0.030 |
Why?
|
| Hernia, Inguinal | 1 | 2015 | 17 | 0.030 |
Why?
|
| Global Health | 1 | 2015 | 58 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 115 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 322 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2015 | 56 | 0.030 |
Why?
|
| Affect | 2 | 2005 | 66 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 21 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 85 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 155 | 0.030 |
Why?
|
| S Phase | 2 | 2004 | 10 | 0.030 |
Why?
|
| E2F Transcription Factors | 2 | 2004 | 5 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 2 | 2004 | 5 | 0.030 |
Why?
|
| Retinoblastoma Protein | 2 | 2004 | 10 | 0.030 |
Why?
|
| Karyotyping | 2 | 2004 | 11 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 249 | 0.030 |
Why?
|
| Health Status | 1 | 2015 | 239 | 0.030 |
Why?
|
| Papanicolaou Test | 1 | 2013 | 9 | 0.030 |
Why?
|
| Vaginal Smears | 1 | 2013 | 15 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2004 | 107 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 404 | 0.030 |
Why?
|
| Mammography | 1 | 2013 | 43 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 174 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 695 | 0.030 |
Why?
|
| Community Health Services | 1 | 2013 | 31 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2015 | 241 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 89 | 0.030 |
Why?
|
| Polysomnography | 1 | 2013 | 99 | 0.030 |
Why?
|
| Actigraphy | 1 | 2013 | 99 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2003 | 329 | 0.030 |
Why?
|
| Health Behavior | 1 | 2013 | 163 | 0.030 |
Why?
|
| Overweight | 1 | 2013 | 69 | 0.030 |
Why?
|
| Hypertension | 1 | 2014 | 288 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2011 | 15 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 20 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 40 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2011 | 27 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 4 | 0.020 |
Why?
|
| Androgens | 1 | 2010 | 7 | 0.020 |
Why?
|
| Saliva | 1 | 2010 | 56 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 97 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2010 | 17 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2009 | 50 | 0.020 |
Why?
|
| Lactation | 1 | 2010 | 63 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2009 | 60 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 5192 | 0.020 |
Why?
|
| Behavioral Medicine | 1 | 2008 | 4 | 0.020 |
Why?
|
| Torque | 1 | 2008 | 27 | 0.020 |
Why?
|
| Rotation | 1 | 2008 | 142 | 0.020 |
Why?
|
| Patient Participation | 1 | 2008 | 53 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 312 | 0.020 |
Why?
|
| Mothers | 1 | 2010 | 184 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 28 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2008 | 238 | 0.020 |
Why?
|
| Aromatase | 1 | 2006 | 3 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2006 | 3 | 0.020 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 5 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 5 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2006 | 9 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2008 | 152 | 0.020 |
Why?
|
| Health Surveys | 1 | 2006 | 99 | 0.020 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2005 | 7 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2005 | 14 | 0.020 |
Why?
|
| Semicircular Canals | 1 | 2005 | 7 | 0.020 |
Why?
|
| Medical Records | 1 | 2005 | 34 | 0.020 |
Why?
|
| Seasons | 1 | 2005 | 32 | 0.020 |
Why?
|
| Arousal | 1 | 2005 | 44 | 0.020 |
Why?
|
| Space Perception | 1 | 2004 | 26 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 72 | 0.020 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2004 | 1 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2005 | 218 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 53 | 0.010 |
Why?
|
| Granulocytes | 1 | 2003 | 23 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 35 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 80 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 158 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 178 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 105 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 168 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 2063 | 0.010 |
Why?
|
| Memory | 1 | 2004 | 328 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2003 | 81 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 232 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 430 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 271 | 0.010 |
Why?
|